BioSpace News Archive

FDA

Lutris Pharma Receives FDA Orphan Drug Designation for LUT014 for the Treatment of EGFRI-Induced Acneiform Rash

Lutris Pharma today announced that the U.S. Food and Drug Administration’s (FDA) Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to lead compound, LUT014.

February 28, 2024
·
4 min read
Biotech Beach

Ionis to present at upcoming investor conferences - February 28, 2024

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences.

February 28, 2024
·
1 min read
Genetown

Access Vascular Supports Updated Standards of Care Emphasizing New Materials to Reduce Catheter Complications

Access Vascular, Inc. announced that the Infusion Nurses Society has updated its standard of care to include innovative catheter materials, to reduce the risk of vascular access complications.

February 28, 2024
·
3 min read
Exscientia to Present at Upcoming Investor Conferences in March - February 28, 2024

Exscientia plc (Nasdaq: EXAI) today announced that members of management will participate in the following upcoming investor conferences in March.

February 28, 2024
·
1 min read
Pharm Country

Blue Earth Therapeutics Announces Participation in Upcoming B. Riley Securities Radiopharma Investor Conference

Blue Earth Therapeutics today announced that it will be presenting at the upcoming B. Riley Securities’ Radiopharma Investor Conference. The event will be held in New York, N.Y., on March 1, 2024.

February 28, 2024
·
3 min read